[ad_1] London CNN Business — The CEO of Barclays said Monday that he has been diagnosed with cancer. C.S. Venkatakrishnan, who is known as Venkat at the bank, said in a note to colleagues that he will begin undergoing treatment for Non-Hodgkin lymphoma at Memorial Sloan Kettering Cancer Center in …
Read More »
[ad_1] The U.K. has been beset by political and economic instability in recent months, but as the investment environment undergoes a fundamental transition, investors see opportunity. The makeup of the U.K.’s FTSE 100 differs considerably from many major developed markets, in that it is heavily-weighted toward consumer staples, financials and …
Read More »
[ad_1] Investors should sell biopharma stock Amgen ahead of its obesity drug update Nov. 7, according to Barclays. Analyst Carter Gould downgraded Amgen to underweight from equal weight, saying there are high expectations around its obesity drug AMG133 after the stock rallied 21.5% in October. Amgen holds an analyst call …
Read More »